ASCVD 10-Year Risk Calculator (with South Asian Adjustment)
Calculate the 10-year risk of atherosclerotic cardiovascular disease (heart attack or stroke) using ACC/AHA Pooled Cohort Equations. Includes South Asian ethnicity multiplier per 2018 ACC/AHA guidelines.
Auto-calculate ASCVD risk at every annual checkup
EasyClinic pulls the latest lipid profile and BP from patient charts, calculates ASCVD score automatically, and prompts you to update statin therapy when risk crosses 7.5% — built-in preventative cardiology.
Also Known As
What is the ASCVD Risk Calculator?
The ASCVD (Atherosclerotic Cardiovascular Disease) Risk Calculator estimates a patient's 10-year probability of having a heart attack, stroke, or dying from coronary heart disease. It uses the Pooled Cohort Equations (PCE) developed by the American College of Cardiology (ACC) and American Heart Association (AHA) in 2013 and updated in 2018.
The calculator is the cornerstone of primary prevention — deciding when to initiate statin therapy in patients without established cardiovascular disease. It's used daily by general practitioners, internists, cardiologists, endocrinologists, and family physicians worldwide.
Why South Asians Need an Adjusted Risk Score
Indians, Pakistanis, Bangladeshis, and Sri Lankans (collectively "South Asians") develop coronary artery disease 5-10 years earlier than Caucasians and at lower BMI and lipid levels. The landmark INTERHEART study (Yusuf et al, Lancet 2004) showed South Asians have a 2× higher prevalence of premature CAD, partly due to:
- Higher visceral adiposity at lower BMI ("thin-fat Indian" phenotype)
- Higher prevalence of insulin resistance and metabolic syndrome
- Elevated lipoprotein(a) [Lp(a)] levels
- Lower HDL-C and higher triglycerides
- Genetic predisposition (9p21 variants, APOE alleles)
The 2018 ACC/AHA Cholesterol Guidelines specifically list "South Asian ancestry" as a "risk-enhancing factor" that should prompt clinicians to favor statin initiation in patients with borderline (5-7.5%) or intermediate (7.5-20%) risk. A multiplier of 1.4-1.5× the baseline PCE risk is commonly applied in clinical practice.
ASCVD Risk Categories and Statin Recommendations
- Low risk (<5%): Lifestyle modification. Reassess every 4-6 years. No statin.
- Borderline (5-7.5%): Discuss risk-enhancers. Consider moderate-intensity statin if South Asian ethnicity, family history of premature CAD, CKD, metabolic syndrome, hs-CRP ≥2, Lp(a) ≥50, or persistent LDL ≥160.
- Intermediate (7.5-20%): Initiate moderate-to-high-intensity statin. Consider CAC (coronary artery calcium) scoring if patient uncertain.
- High (≥20%): Initiate high-intensity statin. Target ≥50% LDL-C reduction.
Statin choices in India: Atorvastatin (Atorva, Storvas) 10/20/40/80 mg, Rosuvastatin (Crestor, Rozavel, Rosuvas) 5/10/20/40 mg, Simvastatin 10/20/40 mg, Pravastatin 10/20/40 mg.
When NOT to Use This Calculator
The PCE is not validated in the following scenarios — these patients are automatically considered high-risk and require statin therapy without further calculation:
- Established clinical ASCVD (prior MI, stroke, PAD, coronary revascularisation)
- LDL-C ≥190 mg/dL (likely familial hypercholesterolemia)
- Type 1 or Type 2 Diabetes age 40-75 with LDL-C 70-189
- Age <40 or >79 (PCE not validated outside this range)
- Total cholesterol >320 mg/dL (use specialist evaluation)
Frequently Asked Questions
▸What is a normal 10-year ASCVD risk?
For low-risk individuals (young, non-smokers, normal BP and lipids), 10-year risk is typically <5%. The risk increases with age — even healthy 70-year-olds often have risks of 10-15%. Always interpret in context.
▸Should I trust the ASCVD calculator for my Indian patients?
The calculator alone may underestimate risk in South Asians by 30-40%. We apply a 1.4× multiplier per ACC/AHA recommendations. For high-stakes decisions, consider additional tools like coronary artery calcium (CAC) scoring or carotid IMT.
▸When should I start a statin?
Start moderate-intensity statin if 10-year risk is 7.5-20% with shared decision-making. Start high-intensity statin if risk ≥20%, established ASCVD, LDL ≥190, or diabetes age 40-75 with LDL 70-189.
▸What is high-intensity statin therapy?
Atorvastatin 40-80 mg or Rosuvastatin 20-40 mg daily — these typically reduce LDL-C by ≥50%. Start moderate intensity (Atorvastatin 10-20, Rosuvastatin 5-10) and titrate up if LDL goal not met.
▸Can I use this calculator for someone with diabetes?
Yes, but remember: diabetic patients aged 40-75 with LDL 70-189 should be on at least moderate-intensity statin regardless of ASCVD score (per ACC/AHA Diabetes Statin recommendation).
▸How often should ASCVD risk be reassessed?
Every 4-6 years for low-risk patients. Annually for borderline/intermediate-risk patients on lifestyle therapy. After lipid changes or new diagnoses (HTN, DM).
▸What is a CAC score and when should it be used?
Coronary Artery Calcium (CAC) scoring uses CT to quantify calcified plaque. Useful when ASCVD score is borderline (5-7.5%) and statin decision is uncertain. CAC = 0 has very low risk; CAC ≥100 reclassifies patient to high risk regardless of PCE score.
References
- Goff DC Jr et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation 2014;129(25 Suppl 2):S49-73
- Grundy SM et al. 2018 ACC/AHA/Multisociety Guideline on the Management of Blood Cholesterol. JACC 2019;73(24):e285-e350
- Yusuf S et al. INTERHEART Study — Lancet 2004;364:937 (South Asian CVD risk)
- Cardiological Society of India (CSI) Position Statement on Lipid Management (2020)
Track lipid panels and CVD risk longitudinally
EasyClinic stores every lipid profile, calculates ASCVD score automatically at every visit, and visualises 10-year risk trends — perfect for chronic disease management and statin compliance tracking.